Company / AR per Share
Mirum Pharmaceuticals, Inc. AR per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$2.55
FY2025
5-year range
$0.11 / $2.55
FY2021-FY2025
Trend
+52.3%
vs FY2024
Sector context
#37 of 115
Health Care
What the data says
At $2.55, Mirum Pharmaceuticals, Inc.'s ar per share ranks #37 of 115 in the Health Care sector. Improved from $1.84 to $2.55 over the past 2 years.
Based on SEC 10-K filings.
2.55 in FY2025 with a 3-year CAGR of +48.2%.
Improved from $1.84 to $2.55 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +48.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#37 of 115 in Health CareTop 32% of 115This company $2.55 Sector average $27.05
▼
-90.6% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 52.3% year-over-year.
- Ranks #37 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.55 | +52.3% |
| FY2024 | $1.68 | -8.9% |
| FY2023 | $1.84 | +134.4% |
| FY2022 | $0.78 | +615.1% |
| FY2021 | $0.11 | - |
| FY2020 | $0.00 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026